KBC Group NV »

Celldex Therapeutics shares owned by KBC Group NV

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-03-31 $67k 1.6k 42.24